Global Coagulation Analyzer Market By Product Type (Analyzers, Clinical Laboratory Analyzers, Point of Care Analyzers, and Others), By Technology (Mechanical, Electrochemical, Optical, and Other Technologies), By End-Use (Hospitals, Research Institutes, Diagnostic Centers, and Other End-Uses), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: May 2023
- Report ID: 65510
- Number of Pages: 323
- Format:
- keyboard_arrow_up
Quick Navigation
Coagulation Analyzer Market Overview:
The global coagulation analyzer market was valued at USD 4,033 million in 2021. They are expected to increase at a 9.6% CAGR over the forecast period.
Due to an increasing number of people suffering from lifestyle-related diseases and chronic blood disorders, coagulation analyzers will be in high demand.
Increasing awareness of these conditions will improve diagnostic rates and preventive care management. This is expected to significantly increase testing volume.
Global Coagulation Analyzer Market Scope:
Product Type Analysis
The majority of 2021’s total revenue was retained by analyzers and they are expected to continue growing at a high CAGR for the forecast period. The factors expected to promote this lucrative growth include the development of healthcare infrastructure, rising healthcare expenditure, and increasing incidences of lifestyle-related conditions like obesity, diabetes, heart disease, and other disorders.
The growth of the diagnostic market is expected to be driven by a greater emphasis on quality and timely care for patients. This will in turn lead to a rise in demand for hemostasis analyzers.
2021 saw the highest share of clinical laboratory segments. The majority of clinical laboratory analyzers are used in hospitals to perform hematological analyses on patients.
Consumables accounted for 64.1% of the market share. They can be further divided into reagents or stains. Hospitals place large quantities or repeat orders of these products because all tests require reagents. This leads to increased demand. These consumables will be more popular due to the increasing number of tests and the development of new assays.
Technology Analysis
The highest growth rate is expected to be in optical technology over the forecast period. This is due to the combination of immunological and chromogenic techniques with photo-optical methods, which has led to the creation of multipurpose, high-performance optical hemostasis analyzers.
Optical technology is further sub-segmented into photo-optical/chromogenic/immunological, and others. Other segments include patented technologies from industry players like Instrumentation Laboratory, Beckman Coulter Inc., and Siemens Healthcare.
By End-Use
The rapid expansion of hospitals and primary care centers is expected to have a significant impact on the future. Future growth will also be supported by government initiatives that improve healthcare delivery. The availability of high-quality equipment that can perform multiple tests with greater accuracy is another important driver of growth.
Hospitals, diagnostic centers, research institutions, and others are the end-users of hemostatic analyzers. Due to the growing trend of outsourcing hemostasis testing to diagnostic centers, the leading end-user segment was dominated by hospitals in 2019.
Hospitals are expected to experience lucrative growth due to rapid expansion and the availability of consumables and analyzers that are based on hospital requirements.
Кеу Маrkеt Ѕеgmеntѕ
By Product Type
- Analyzers
- Point of Care Analyzers
- Stains
- Consumables
- Reagents
- Clinical Laboratory Analyzers
By Technology
- Mechanical
- Optical
- Electrochemical
- Other Technologies
By End-Use
- Hospitals
- Diagnostic Centers
- Research Institutes
- Other End-Uses
Market Dynamics:
The countries studied are currently going through a paradigm shift. They are spending huge amounts of public funds to purchase and install these medical devices in their public health facilities. Over the next few years, the Middle East and the Asia Pacific regions will see an increase in the number of geriatrics, a rising incidence of chronic diseases, and a rapid rise in foreign investment.
According to WHO reports, hemophilia is another reason for industry growth. This leads to an increase in medical device installations and the expansion of healthcare facilities.
Regional Analysis
North America is the dominant market for coagulation analyzers and will contribute 37.1% to the overall revenue share. The market’s growth was helped by the availability of good healthcare and the rising prevalence of cardiometabolic disorders like Deep Vein Thrombosis, DVT, and Pulmonary Embolism (PE).
Due to the availability of hospitals, health centers, and clinics, as well as skilled healthcare personnel, the Middle East and Africa are expected to experience a significant growth rate.
Key Regions and Countries covered іn thе rероrt:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
These key players include Instrumentation Laboratory, Roche Diagnostics, and Siemens Healthcare. These players are mainly present in international markets and are competing for a larger share of the market because they have easy access to global resources.
Currently, the majority of players use third-party vendors to distribute these products. Sysmex, for example, entered into a distribution deal with Dade Behring. This is now part of Siemens Healthcare Diagnostics. This trend is expected to change due to increased investment by the players in the region to set up their distribution offices. Direct supply agreements will continue to gain momentum during the forecast period.
Маrkеt Кеу Рlауеrѕ:
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific Inc.
- Instrumentation Laboratory Werfen Group
- Helena Laboratories
- Nihon Kohden Corp.
- International Technidyne Corp.
- Diagnostic Stago
- Аlеrе
- Ѕуѕmех Corp.
- Other Key Players
For the Coagulation Analyzer Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
Q: What is the size of the coagulation analyzer market in 2021?A: The Coagulation analyzer market size is US$ 4,033 million in 2021.
Q: What is the projected CAGR at which the Coagulation analyzer market is expected to grow at?A: The Coagulation analyzer market is expected to grow at a CAGR of 9.6% (2023-2032).
Q: List the segments encompassed in this report on the Coagulation analyzer market?A: Market.US has segmented the Coagulation analyzer market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type, the market has been segmented into, Analyzers, Clinical Laboratory Analyzers, Point of Care Analyzers, Consumables, Reagents, and Stains. By Technology, the market has been further divided into, Mechanical, Electrochemical, Optical, Other Technologies. By End-Use, the market has been further divided into, Hospitals, Research Institutes, Diagnostic Centers, and Other End-Uses.
Q: List the key industry players of the Coagulation analyzer market?A: Roche Diagnostics, Siemens Healthcare, Thermo Fisher Scientific Inc., Instrumentation Laboratory Werfen Group, Helena Laboratories, Nihon Kohden Corp., International Technidyne Corp., Diagnostic Stago, and Other Key Players engaged in the Coagulation Analyzer market.
Q: Which region is more appealing for vendors employed in the Coagulation analyzer market?A: North America is expected to account for the highest revenue share of 37.1%. Therefore, the Coagulation analyzer industry in North America is expected to garner significant business opportunities over the forecast period.
Q: Name the key areas of business for Coagulation Analyzer?A: India, China, The US, Canada, UK, Japan, & Germany are key areas of operation for the Coagulation Analyzer Market.
Q: Which segment accounts for the greatest market share in the Coagulation analyzer industry?A: With respect to the Coagulation analyzer industry, vendors can expect to leverage greater prospective business opportunities through the analyzers segment, as this area of interest accounts for the largest market share.
Coagulation Analyzer MarketPublished date: May 2023add_shopping_cartBuy Now get_appDownload Sample - Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific Company Profile
- Instrumentation Laboratory Werfen Group
- Helena Laboratories
- Nihon Kohden Corp.
- International Technidyne Corp.
- Diagnostic Stago
- Аlеrе
- Ѕуѕmех Corp.
- Other Key Players
- settingsSettings
Our Clients
Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |